New drug ZL-1310 tested against hard-to-treat cancers
NCT ID NCT06885281
First seen Jan 05, 2026 · Last updated Apr 29, 2026 · Updated 18 times
Summary
This study tests an experimental drug called ZL-1310 in about 112 adults with advanced neuroendocrine carcinomas (a type of solid tumor) that have worsened after standard chemotherapy. The main goals are to check safety and see if the drug can shrink tumors. Participants must have a measurable tumor and provide a tissue sample. This is an early-phase trial, so the drug is not yet proven to work.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zai Lab Site 1001
RECRUITINGShanghai, Shanghai Municipality, 200000, China
Contact
-
Zai Lab Site 1002
RECRUITINGBeijing, Beijing Municipality, 100142, China
Contact
-
Zai Lab Site 1004
RECRUITINGGuangzhou, Guangdong, 510080, China
Contact
-
Zai Lab Site 1006
RECRUITINGChangsha, Hunan, 410013, China
Contact
-
Zai Lab Site 1008
RECRUITINGChangchun, Jilin, 130012, China
Contact
-
Zai Lab Site 1009
RECRUITINGXiamen, Fujian, 361003, China
Contact
-
Zai Lab Site 1012
RECRUITINGHarbin, Heilongjiang, 150081, China
Contact
-
Zai Lab Site 1013
RECRUITINGBeijing, Beijing Municipality, 102200, China
Contact
-
Zai Lab Site 1016
RECRUITINGGuangzhou, Guangdong, 510030, China
Contact
-
Zai Lab Site 2001
RECRUITINGSan Francisco, California, 94143, United States
Contact
-
Zai Lab Site 2002
RECRUITINGNew York, New York, 10065, United States
Contact
-
Zai Lab Site 2003
RECRUITINGDallas, Texas, 75246, United States
Contact
-
Zai Lab Site 2004
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
Contact
-
Zai Lab Site 2006
RECRUITINGFairfax, Virginia, 22031, United States
Contact
-
Zai Lab Site 2007
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Zai Lab Site 2011
NOT_YET_RECRUITINGMcAllen, Texas, 78503, United States
Contact
-
Zai Lab Site 2012
NOT_YET_RECRUITINGNorfolk, Virginia, 23502, United States
Contact
-
Zai Lab Site 2013
RECRUITINGDetroit, Michigan, 48201, United States
Contact
-
Zai Lab Site 2014
NOT_YET_RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
Zai Lab Site 2024
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Conditions
Explore the condition pages connected to this study.